Changes of Tear-film Lipid Layer Thickness and Ocular Aberration After Treatment of Meibomian Gland Dysfunction
Status:
Completed
Trial end date:
2016-02-19
Target enrollment:
Participant gender:
Summary
In this study, investigator aim to evaluate the changes of tear-film lipid layer thickness
and ocular aberration after treatment of meibomian gland dysfunction. In case of stage 3 or 4
meibomian gland dysfunction, participants will be treated using conventional treatment
modalities. Before treatment and after 1 and 2 months of treatment, a variety of ophthalmic
examination, tear-film lipid layer thickness, and ocular aberration are going to measured and
compared.